Absci Corp (NAS:ABSI)
$ 2.77 -0.21 (-7.05%) Market Cap: 342.27 Mil Enterprise Value: 230.64 Mil PE Ratio: 0 PB Ratio: 1.69 GF Score: 54/100

Q1 2024 Absci Corp Earnings Call Transcript

May 14, 2024 / 12:00PM GMT
Release Date Price: $4.83 (-4.55%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Absci's first-quarter 2024 business update call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would like now to turn the conference over to Alex Khan, Vice President, Finance and Investor Relations. Please go ahead.

Alexander Khan
Absci Corp - VP, Finance and IR

Thank you. Earlier today, ads released financial and operating results for the quarter ended March 31st, 2024. If you haven't received this news release or if you'd like to be added to the Company's distribution list, please send an e-mail to investors at outside.com. An archived webcast of this call will be available for replay on our Investor Relations website at investors dot exide.com for at least 90 days after this call.

Joining me today are Sean McClain, our Founder and CEO; and Zach Jonasson, Chief Financial Officer and Chief Business Officer. Christian Stegmann, Absci's SVP of Drug Creation will also join for Q&A following prepared remarks.

Before we begin,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot